Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Rhythm Pharmaceuticals stock

Learn how to easily invest in Rhythm Pharmaceuticals stock.

Rhythm Pharmaceuticals Inc is a biotechnology business based in the US. Rhythm Pharmaceuticals shares (RYTM) are listed on the NASDAQ and all prices are listed in US Dollars. Rhythm Pharmaceuticals employs 140 staff and has a trailing 12-month revenue of around $13.4 million.

How to buy shares in Rhythm Pharmaceuticals

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – RYTM – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Rhythm Pharmaceuticals stock price (NASDAQ: RYTM)

Use our graph to track the performance of RYTM stocks over time.

Rhythm Pharmaceuticals shares at a glance

Information last updated 2022-09-25.
Latest market close$24.76
52-week range$3.04 - $30.98
50-day moving average $20.45
200-day moving average $10.69
Wall St. target price$30.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-3.31

Buy Rhythm Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Rhythm Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Rhythm Pharmaceuticals price performance over time

Historical closes compared with the close of $24.76 from 2022-09-28

1 week (2022-09-22) 2.95%
1 month (2022-08-29) 12.44%
3 months (2022-06-29) 479.86%
6 months (2022-03-25) N/A
1 year (2021-09-29) 87.72%
2 years (2020-09-29) 11.18%
3 years (2019-09-27) 16.85%
5 years (2017-09-25) N/A

Rhythm Pharmaceuticals financials

Revenue TTM $13.4 million
Gross profit TTM $2.6 million
Return on assets TTM -36.22%
Return on equity TTM -64.22%
Profit margin 0%
Book value $3.88
Market capitalisation $1.2 billion

TTM: trailing 12 months

Rhythm Pharmaceuticals share dividends

We're not expecting Rhythm Pharmaceuticals to pay a dividend over the next 12 months.

Rhythm Pharmaceuticals share price volatility

Over the last 12 months, Rhythm Pharmaceuticals's shares have ranged in value from as little as $3.04 up to $30.98. A popular way to gauge a stock's volatility is its "beta".

RYTM.US volatility(beta: 2.22)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Rhythm Pharmaceuticals's is 2.2217. This would suggest that Rhythm Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Rhythm Pharmaceuticals overview

Rhythm Pharmaceuticals, Inc. , a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is also developing setmelanotide, which is in Phase II clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, Smith-Magenis syndrome obesity, POMC epigenetic disorders, and other MC4R disorders. Rhythm Pharmaceuticals, Inc. has a collaborative research agreement with the Clinical Registry Investigating Bardet-Biedl Syndrome. The company was formerly known as Rhythm Metabolic, Inc.

Frequently asked questions

What percentage of Rhythm Pharmaceuticals is owned by insiders or institutions?
Currently 0.316% of Rhythm Pharmaceuticals shares are held by insiders and 85.113% by institutions.
How many people work for Rhythm Pharmaceuticals?
Latest data suggests 140 work at Rhythm Pharmaceuticals.
When does the fiscal year end for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals's fiscal year ends in December.
Where is Rhythm Pharmaceuticals based?
Rhythm Pharmaceuticals's address is: 222 Berkeley Street, Boston, MA, United States, 02116
What is Rhythm Pharmaceuticals's ISIN number?
Rhythm Pharmaceuticals's international securities identification number is: US76243J1051
What is Rhythm Pharmaceuticals's CUSIP number?
Rhythm Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 76243J105

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site